Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC

ConclusionsDeleterious mutations of these six genes were common in resected NSCLC and could serve as prognostic biomarkers.

Source: Thoracic Cancer - September 14, 2023 Category: Cancer & Oncology Authors: Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wang Tags: ORIGINAL ARTICLE Source Type: research